← Back⌂ All journals
Review of Artificial Intelligence in Educatione-ISSN 2965-4688v. 14 (2026)Open Access1 min read

Analysis of miRNA Expression Stratified by Sex in Patients with Lung Adenocarcinoma

Análise da Expressão de miRNAs Estratificada por Sexo em Pacientes com Adenocarcinoma Pulmonar

  1. BRFaculdade SENAI – Campus Suíço-Brasileira, São Paulo, SP
  2. BRUniversidade Estadual Paulista “Júlio de Mesquita Filho” (UNESP), São Paulo, SP
  3. CABC Cancer Research Centre, Integrative Oncology, São Paulo, SP
Read as flipbookPDF (English)PDF (Português)All articles in this issueCite this article

Abstract

Introduction

Sex-related biological differences may contribute to the molecular heterogeneity of LUAD, including variations in miRNA expression.

Objective

To identify sex-specific miRNAs associated with LUAD and evaluate their associations with patient survival and enriched biological pathways.

Methods

miRNA expression and clinical data from The Cancer Genome Atlas were analyzed separately for male and female patients. Differential expression, survival, and pathway enrichment analyses were performed.

Results

A total of 130 differentially expressed miRNAs were identified in males and 208 in females. Two miRNAs were associated with survival in the male group and eight in the female group. Pathway enrichment analysis revealed distinct functional profiles between the groups.

Conclusion

These exploratory findings indicate sex-related differences in miRNA expression patterns and their associations with survival and biological pathways in LUAD, providing a basis for future studies investigating their potential prognostic relevance.

Keywords
BiostatisticsLung cancerSurvival AnalysisPathway enrichmentBiomarkers

References 38

  1. Aparicio-Puerta, E., Hirsch, P., Schmartz, G. P., Kern, F., Fehlmann, T., & Keller, A. (2023). miEAA 2023: Updates, new functional microRNA sets and improved enrichment visualizations. Nucleic Acids Research, 51(W1), W319–W325. https://doi.org/10.1093/nar/gkad392
  2. Caserta, S., Manca, P., Rinaldi, L., Mazzoni, F., De Summa, S., & Tommasi, S. (2023). Gender differences and miRNAs expression in cancer: Implications on prognosis and susceptibility. International Journal of Molecular Sciences, 24(14), 11544. https://doi.org/10.3390/ijms241411544
  3. da Rocha Camargo, B., de Souza, V. D. G. P., Lapa, R. M. L., dos Reis, P. P., & Oliveira, R. A. (2023). A decision tree-based classifier compares three data analysis methods for the identification of miRNAs associated with early-stage lung cancer. Revista Foco, 16(5), e2031. https://doi.org/10.54751/revistafoco.v16n5-084
  4. Fu, Y., Liu, J., Chen, Y., Liu, Z., Xia, H., & Xu, H. (2023). Gender disparities in lung cancer incidence in the United States during 2001–2019. Scientific Reports, 13, 12581. https://doi.org/10.1038/s41598-023-39440-8
  5. Gagolewski, M. (2022). stringi: Fast and portable character string processing in R. Journal of Statistical Software, 103(2), 1–59. https://doi.org/10.18637/jss.v103.i02
  6. Griffiths-Jones, S. (2004). The microRNA registry. Nucleic Acids Research, 32(Suppl. 1), D109–D111. https://doi.org/10.1093/nar/gkh023
  7. Haranguș, A., Munteanu, R., Ciocan-Cârjă, O., Berindan-Neagoe, I., & Braicu, C. (2022). Identification of potential microRNA panels for male non-small cell lung cancer identification using microarray datasets and bioinformatics methods. Journal of Personalized Medicine, 12(12), 2056. https://doi.org/10.3390/jpm12122056
  8. Hayden, M. S., West, A. P., & Ghosh, S. (2006). NF-κB and the immune response. Oncogene, 25(51), 6758–6780. https://doi.org/10.1038/sj.onc.1209943
  9. Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., ... Meyerson, M. (2012). Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell, 150(6), 1107–1120. https://doi.org/10.1016/j.cell.2012.08.029
  10. Iozzo, R. V., & Sanderson, R. D. (2011). Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. Journal of Cellular and Molecular Medicine, 15(5), 1013–1031. https://doi.org/10.1111/j.1582-4934.2010.01236.x
  11. Jansson, M. D., & Lund, A. H. (2012). MicroRNA and cancer. Molecular Oncology, 6(6), 590–610. https://doi.org/10.1016/j.molonc.2012.09.006
  12. Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481. https://doi.org/10.1080/01621459.1958.10501452
  13. Kassambara, A., Kosinski, M., & Biecek, P. (2021). survminer: Drawing survival curves using “ggplot2” (R package version 0.4.9). https://CRAN.R-project.org/package=survminer
  14. Li, X., Wei, S., Deng, L., Tao, H., Liu, M., Zhao, Z., Du, X., Li, Y., & Hou, J. (2023). Sex-biased molecular differences in lung adenocarcinoma are ethnic and smoking specific. BMC Pulmonary Medicine, 23, 99. https://doi.org/10.1186/s12890-023-02387-7
  15. Liu, Q., Wang, Y., Duan, M., Fan, Y., Pan, X., Liu, S., Yu, Q., Huang, L., & Zhou, F. (2021). Females and males show differences in early-stage transcriptomic biomarkers of lung adenocarcinoma and lung squamous cell carcinoma. Diagnostics, 11(2), 347. https://doi.org/10.3390/diagnostics11020347
  16. Lopes-Ramos, C. M., Quackenbush, J., & DeMeo, D. L. (2020). Genome-wide sex and gender differences in cancer. Frontiers in Oncology, 10, 597788. https://doi.org/10.3389/fonc.2020.597788
  17. Mantel, N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 50(3), 163–170.
  18. May, L., Bonomi, M., Fidler, M. J., Borgia, J. A., & Bonomi, P. (2023). Sex differences in lung cancer. Cancers, 15(12), 3111. https://doi.org/10.3390/cancers15123111
  19. Myers, D. J., & Wallen, J. M. (2022). Lung adenocarcinoma. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK519578/
  20. Patel, D., McElroy, J. P., Weng, D. Y., Sahar, K., Reisinger, S. A., Freudenheim, J. L., Wewers, M. D., Shields, P. G., & Song, M.-A. (2024). Sex-related DNA methylation is associated with inflammation and gene expression in the lungs of healthy individuals. Scientific Reports, 14, 14280. https://doi.org/10.1038/s41598-024-65027-y
  21. Pezzuto, A., & Carico, E. (2018). Role of HIF-1 in cancer progression: Novel insights. A review. Current Molecular Medicine, 18(6), 343–351. https://doi.org/10.2174/1566524018666181109121849
  22. Poleri, C. (2022). Sex-based differences in lung cancer: Does it matter? Journal of Thoracic Oncology, 17(5), 599–601. https://doi.org/10.1016/j.jtho.2022.03.002
  23. Provenzano, P. P., & Keely, P. J. (2009). The role of focal adhesion kinase in tumor initiation and progression. Cell Adhesion & Migration, 3(4), 347–350. https://doi.org/10.4161/cam.3.4.9458
  24. Qin, T., & Zhang, G. (2025). The role of miR-21 in early-stage lung adenocarcinoma: Clinical and bioinformatics insights. Scientific Reports, 15, 37903. https://doi.org/10.1038/s41598-025-21742-8
  25. Ragavan, M., & Patel, M. I. (2022). The evolving landscape of sex-based differences in lung cancer: A distinct disease in women. European Respiratory Review, 31(163), 210100. https://doi.org/10.1183/16000617.0100-2021
  26. Saha, E., Ben Guebila, M., Fanfani, V., Fischer, J., Shutta, K. H., Mandros, P., DeMeo, D. L., Quackenbush, J., & Lopes-Ramos, C. M. (2024). Gene regulatory networks reveal sex difference in lung adenocarcinoma. Biology of Sex Differences, 15, 62. https://doi.org/10.1186/s13293-024-00634-y
  27. Stabellini, N., Bruno, D. S., Gubens, M. A., Padda, S. K., & Bunn, P. A. (2022). Sex differences in lung cancer treatment and outcomes at a large hybrid academic-community practice. JTO Clinical and Research Reports, 3(4), 100307. https://doi.org/10.1016/j.jtocrr.2022.100307
  28. Tang, J., Li, X., Cheng, T., & Wu, J. (2021). miR-21-5p/SMAD7 axis promotes the progress of lung cancer. Thoracic Cancer, 12(17), 2307–2313. https://doi.org/10.1111/1759-7714.14060
  29. Teo, J.-L., & Kahn, M. (2010). The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators. Advanced Drug Delivery Reviews, 62(12), 1149–1155. https://doi.org/10.1016/j.addr.2010.09.012
  30. The Cancer Genome Atlas. (2018). Genomic Data Commons Data Portal. https://portal.gdc.cancer.gov/
  31. Therneau, T. M. (2022). A package for survival analysis in R (R package version 3.4-0). https://CRAN.R-project.org/package=survival
  32. Wei, D., Yu, G., & Zhao, Y. (2019). MicroRNA-30a-3p inhibits the progression of lung cancer via the PI3K/AKT by targeting DNA methyltransferase 3a. OncoTargets and Therapy, 12, 7015–7024. https://doi.org/10.2147/OTT.S213583
  33. Weisstein, E. W. (2004). Bonferroni correction. Wolfram MathWorld. https://mathworld.wolfram.com/BonferroniCorrection.html
  34. Wickham, H. (2009). ggplot2: Elegant graphics for data analysis. Springer. https://doi.org/10.1007/978-0-387-98141-3
  35. Xie, K., Chen, M., Wang, C., Yu, D., Lu, Y., Wang, C., ... Shen, H. (2015). A functional variant in miR-155 regulation region contributes to lung cancer risk and survival. Oncotarget, 6(40), 42781–42792. https://doi.org/10.18632/oncotarget.5840
  36. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., ... Harris, C. C. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9(3), 189–198. https://doi.org/10.1016/j.ccr.2006.01.025
  37. Zappa, C., & Mousa, S. A. (2016). Non-small cell lung cancer: Current treatment and future advances. Translational Lung Cancer Research, 5(3), 288–300. https://doi.org/10.21037/tlcr.2016.06.07
  38. Zhang, J.-G., Wang, J.-J., Zhao, F., Liu, Q., Jiang, K., & Yang, G.-H. (2010). MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clinica Chimica Acta, 411(11–12), 846–852. https://doi.org/10.1016/j.cca.2010.02.074

Cite this article

BibTeXRIS

Zotero and Mendeley: open the RIS file, or use the Zotero Connector on this page (it reads the article metadata).

Share